Initial Workup and Management of Suspected Pancreatitis
The initial workup for suspected pancreatitis should include serum lipase (preferred over amylase due to higher sensitivity and specificity), complete blood count, comprehensive metabolic panel, liver function tests, calcium, triglycerides, and transabdominal ultrasound to identify gallstones as a potential cause. 1
Diagnostic Criteria
Acute pancreatitis diagnosis requires at least two of the following three criteria:
- Characteristic abdominal pain (upper abdominal pain, often radiating to the back)
- Biochemical evidence (serum lipase or amylase ≥3 times the upper limit of normal)
- Characteristic imaging findings on CT or MRI 1
Initial Laboratory Evaluation
- Serum lipase (preferred) or amylase - elevated >3 times upper limit of normal
- Complete blood count (CBC) - to assess for leukocytosis and hemoconcentration
- Comprehensive metabolic panel (CMP) - to evaluate renal function and electrolytes
- Liver function tests (AST, ALT, bilirubin, alkaline phosphatase) - to evaluate for biliary etiology
- Serum triglycerides - to identify hypertriglyceridemia as a cause
- Serum calcium - to identify hypercalcemia as a potential cause
- C-reactive protein (CRP) - levels ≥150 mg/L at 48-72 hours indicate severe disease 1
- Blood urea nitrogen (BUN) - >20 mg/dL is an independent predictor of mortality 1
Initial Imaging
- Transabdominal ultrasound - first-line imaging to identify gallstones 1
- Contrast-enhanced CT (CECT) - not necessary in all cases, but indicated for:
Severity Assessment
Severity assessment should be performed early to guide management:
- BISAP score ≥2 indicates severe acute pancreatitis 1
- APACHE-II score ≥8 indicates severe disease (most accurate but complex) 1
- Persistent organ failure after 48 hours in hospital 2
- C-reactive protein >150 mg/L after 48 hours 2, 1
- Hematocrit >44% (risk factor for pancreatic necrosis) 1
Initial Management
For All Patients with Suspected Pancreatitis
Fluid Resuscitation
- Aggressive early intravenous fluid resuscitation with crystalloids
- Monitor response with vital signs, urine output, BUN, and hematocrit 1
Pain Management
- Multimodal analgesia with intravenous medications
- Opioids may be necessary for adequate pain control 1
Nutrition
Avoid Prophylactic Antibiotics
- Antibiotics should not be administered routinely in mild cases
- Only indicated for specific infections (respiratory, urinary, biliary, or line-related) 2
Additional Management for Severe Pancreatitis
Intensive Care Management
Biliary Intervention
Management of Complications
Definitive Management of Gallstones
- All patients with biliary pancreatitis should undergo definitive management of gallstones during the same hospital admission or within two weeks 2
Common Pitfalls and Caveats
Diagnostic Pitfalls
- Normal amylase does not exclude pancreatitis in cases of hyperlipidemia, acute exacerbation of chronic pancreatitis, or delayed presentation 3
- Routine monitoring of amylase or lipase in asymptomatic patients is not recommended 2
- Once diagnosis is established, daily enzyme measurements have no value in assessing clinical progress 3
Management Pitfalls
- Avoid overly aggressive fluid resuscitation as it can lead to complications
- Avoid total parenteral nutrition when enteral nutrition is possible
- Avoid prophylactic antibiotics in the absence of documented infection
- Do not delay ERCP in patients with cholangitis or biliary obstruction
- Do not delay definitive management of gallstones in biliary pancreatitis 2, 1
Referral Considerations
- Management in, or referral to, a specialist unit is necessary for patients with:
- Extensive necrotizing pancreatitis
- Other complications requiring intensive care
- Need for interventional radiological, endoscopic, or surgical procedures 2
- Management in, or referral to, a specialist unit is necessary for patients with:
By following this structured approach to the initial workup and management of suspected pancreatitis, clinicians can ensure timely diagnosis, appropriate risk stratification, and optimal treatment to reduce morbidity and mortality.